Studies emphasized the probiotic-induced gut microbiome’s impact on tumor growth and therapy response [31], particularly in how Lactobacillus species activate aryl hydrocarbon receptors (AhR) in tumor-associated macrophages, leading to immunosuppression and tumor progression [32]. The gene discussed is AHR; the disease is neoplasm.